Dr. David Bernard Miklos, MD, PhD

Dr. Miklos practices at Stanford Hospital at 300 Pasteur Drive in Stanford, California, part of Stanford University.

Dr. Miklos' NPI, 1982751053, was assigned on January 4, 2007. Dr. Miklos graduated from Yale School of Medicine in 1995. Dr. Miklos holds California license G87296.

Dr. Miklos' primary practice is Stanford Hospital at 300 Pasteur Drive, at 300 Pasteur Drive, Stanford, CA 94305 in Santa Clara County. The practice phone is (650) 723-4000.

Dr. Miklos' primary practice is Stanford Hospital at 300 Pasteur Drive in Stanford, California, part of Stanford University. The medical group on file is Stanford Health Care. Dmand AI also links Dr. Miklos to 1 more hospital, named with a free account. Dr. Miklos' employer is on file too: a hospital.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Miklos practices, 2 sites in all. Vendor and product names are available with a free account.

Internal medicine is Dr. Miklos' primary specialty in the NPI Registry, under taxonomy code 207RH0000X. The record also lists hematology. Dr. Miklos is board certified in hematology by the American Board of Internal Medicine. Dmand AI has Dr. Miklos' licenses on file in 2 states: California and Massachusetts.

Dmand AI lists chronic leukemia and lymphoma among the conditions Dr. Miklos treats.

CMS data shows 406 Medicare services from Dr. Miklos across 3 procedure codes in 2024, for 104 Medicare patients. Medicare paid $46,931 for them.

CMS counts 104 Medicare patients who saw Dr. Miklos in 2024. The largest group is 65 to 74, with 54 patients. 69% of them have high blood pressure, and 68% have high cholesterol. 21% are also on Medicaid. Their average risk score is 2.67, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Miklos' median patient age at 63, with 41% women.

In 2024, Dr. Miklos wrote 660 Medicare Part D claims for 81 patients. 83% of them were for generic drugs. CMS names the drug for 509 of them, across 13 drugs with 11 or more claims each, at $635,018 in total drug cost.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 89 out of 100 for Dr. Miklos for performance year 2024, reported as part of a group. Dr. Miklos accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Miklos as offering telehealth.

Dmand AI links 134 papers to Dr. Miklos, published from 2003 to 2025. 2021 was the busiest year, with 9. The most frequent topics are Hematopoietic Stem Cell Transplantation, Graft vs Host Disease and Immunotherapy, Adoptive. Dr. Miklos has published most often in Blood. Dr. Miklos' most frequent co-authors are Sally Arai, MD, Robert Stuart Negrin, MD and Robert Lowsky, MD.

Dmand AI links Dr. Miklos to 15 clinical trials, 5 of them phase 2 studies. 4 are still active or recruiting. Conditions studied include Lymphoma, Mantle-Cell, Graft vs Host Disease and Lymphoma. Stanford University sponsors the most, 7.

CMS Open Payments shows 57 general payments to Dr. Miklos from 14 drug and device companies from 2024 to 2025. Consulting fees make up the largest share, 72% of the total. Bristol-Myers Squibb Company paid the most, $5,253.

Dmand AI lists 1 award for Dr. Miklos, most recently CMS Stage 1 EHR in 2012.

Dr. Miklos graduated from Yale School of Medicine in 1995.

Dr. Miklos is in network with 9 carriers, including Aetna, Elevance and Blue Cross Blue Shield of Massachusetts. Medicare plans come from the most carriers, 6. Check the plan with the practice before a visit.